Interconnection of traditional risk factors with the activity of the inflammatory process and atherosclerosis in patients with psoriatic arthritis

Взаимосвязь традиционных факторов риска с активностью воспалительного процесса и атеросклерозом у больных псориатическим артритом
Ludmila Khimion 1, Alina Boiko 1 *
More Detail
1 Family Medicine Department, Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine
* Corresponding Author
J CLIN MED KAZ, Volume 1, Issue 51, pp. 32-36. https://doi.org/10.23950/1812-2892-JCMK-00663
OPEN ACCESS 2807 Views 1817 Downloads
Download Full Text (PDF)

ABSTRACT

The article is devoted to the study of the relationship of traditional risk factors for cardiovascular diseases with the activity of the inflammatory process and atherosclerosis in patients with psoriatic arthritis. The study included 32 patients with PsA who did not have atherosclerotic cardiovascular disease, diabetes, chronic kidney disease and other serious diseases, did not take statins, the control group consisted of 19 patients with psoriasis. It was revealed that in patients with psoriatic arthritis, the severity of the atherosclerotic process is more compared with patients with psoriasis (the risk factors profiles were the same). The highest levels of C-reactive protein, fibrinogen, uric acid, intima-media complex thickness, atherosclerotic plaque frequency were found in patients in the psoriatic arthritis group, which may indicate a pathogenetic association of additional RF with the development of a more common atherosclerotic process.
Keywords: psoriatic arthritis, psoriasis, cardiovascular diseases, dyslipidemia, atherosclerosis, C-reactive protein, uric acid, endothelial dysfunction

CITATION

Khimion L, Boiko A. Interconnection of traditional risk factors with the activity of the inflammatory process and atherosclerosis in patients with psoriatic arthritis. Journal of Clinical Medicine of Kazakhstan. 2019;1(51):32-6. https://doi.org/10.23950/1812-2892-JCMK-00663

REFERENCES

  • Gezer O., Batmaz I., Sariyildiz MA, Sula B, Ucmak D, Bozkurt M, Nas K. Sleep quality in patients with psoriatic arthritis. Int J Rheum Dis. 2017; 20(9):1212-1218. https://doi.org/10.1111/1756-185X.12505
  • Mygind K., Sell L., Flyvholm MA, Jepsen KF. High-fat petrolatum-based moisturizers and prevention of work-related skin problems in wet-work occupations. Contact Dermatitis. 2006; 54 (1):35–41. https://doi.org/10.1111/j.0105-1873.2006.00744.x
  • Badokin V.V. Psoriaticheskiy artrit: klinika. diagnostika. lecheniye: Dissert. d-ra med. Nauk. 2003.
  • Alenius G.M., Jidell E., Nordmark L. Clinical data and lipids in psoriatic arthritis. J. Rheumatol. 1998; 25(54):39.
  • Han C., Robinson D.W., Hackett M.V., Paramore LC, Fraeman KH, Bala MV. Cardiovascular disease and risk factors in pathients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J. Rheumatol. 2006; 33(11):2167-2172.
  • Jones S.M., Harris C.P.D., Lloyd J. Stirling CA, Reckless JP, McHugh NJ. Lipoproteins and their subfractions in psoriatic arthritis: identification of an atherogenic profile with active joint disease. Ann. Rheum. Dis. 2000; 59(5):904-909. https://dx.doi.org/10.1136%2Fard.59.11.904
  • Uyanik B.S., Ari Z., Onur E., Gündüz K, Tanülkü S, Durkan K. Serum lipids and apolipoproteins in patients with psoriasis. Clin. Chem. Lab. Med. 2002; 40(1):65-68. https://doi.org/10.1515/CCLM.2002.013
  • Mіtchenko O.І.. Lutay M.І. Dislіpіdemії: dіagnostika. profіlaktika ta lіkuvannya. Metodichnі rekomendatsії asotsіatsії kardіologіv Ukraїni. Morіon. 2011.
  • Titov V. N. Vzaimosvyaz mochevoy kisloty s pokazatelyamya lipidnogo obmena u lits s nizkim i srednim riskom po shkale SCORE. Ateroskleroz i dislipidemii. 2013; 2:31-39.
  • Delgado G., Siekmeier R, Krämer BK, März W, Kleber ME. Alterations in the coagulation system of active smokers from the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Adv Exp Med Biol. 2015; 858:69-77. https://doi.org/10.1007/5584_2015_127
  • Plasma Fibrinogen Level and the Risk of Major Cardiovascular Diseases and Nonvascular Mortality: An Individual Participant Metaanalysis. Fibrinogen Studies Collaboration. JAMA. 2005; 294:1799-1809. https://doi.org/10.1001/jama.294.14.1799
  • Lubrano V. Balzan S. Consolidated and emerging inflammatory markers in coronary artery disease. World J Exp Med. 2015; 1(5):21-32. 87. https://doi.org/10.5493/wjem.v5.i1.21
  • Lindahl B., Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-tem mortality in unstable coronary artery disease. The New England Journal of Medicine. 2000; 16 (343):1139-1147. https://doi.org/10.1056/NEJM200010193431602
  • Pignoli P., Longo T. Ultrasound evaluation of atherosclerosis. Methodological problems and technological developments. Eur. Surg. Res. 1986; 18: 238-53. https://doi.org/10.1159/000128532
  • Gonzalez-Juanatey C., Llorca J., Amigo-Diaz E. High prevalence of subclinical atherosclerosis in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum. 2007; 57(6):1074-1080. https://doi.org/10.1002/art.22884
  • Leong T. T, Fearon U., Veale D. J. Angiogenesis in psoriasis and psoriatic arthritis: Clues to disease pathogenesis. Curr. Rheum. Rep. 2005; 7(4):325-329.
  • Khimion L.V., Lysenko G.I., OB Yashchenko, S.V. Danilyuk, L.F. Matyuha Ateroskleroz:sovremennyye podkhody k vedeniyu patsiyentov. Ratcionalnaya farmakoterapia. 2008.
  • V.M. Kovalenko, L.V. Khimion, G.І. Lysenko, O.O. Garmisch Vpliv іmunnogo statusu і lіpіdnikh faktorіv na progresuvannya subklіnіchnogo aterosklerozu і rozvitok sertsevo-sudinnikh zakhvoryuvan u patsієntіv іz revmatoїdnim artritom. Ukr. tevmatol. Zhurn. 2011.
  • Isaac T., Cheng, Qing Shang, Edmund K. Li. Can Achieving Minimal Disease Activity Prevent Progression of Subclinical Atherosclerosis and Arterial Stiffness? A Prospective Cohort Study in Psoriatic Arthritis. Arthritis Reumatol. 2018. https://doi.org/10.1002/art.40695